Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
How BCL-2 Binding Relates to Cell Death
2026-11-17
TW-37 is documented as a BH3-groove binder with reported activity against several BCL-2-family proteins. Its binding constants support a molecular interaction model, while the reported cell-cycle, apoptosis, signaling and angiogenesis findings describe downstream biological consequences that remain context dependent.
Quantifying Organelle Proximity by Super-Resolution
2026-11-16
A methods-focused study shows how Airyscan and structured illumination imaging, combined with feature-based pixel classification, can improve the representation and quantitative analysis of organelle morphology and proximity. The evidence supports a reproducible image-analysis strategy in the evaluated datasets, while mask overlap remains an indirect indicator rather than proof of molecular tethering.
How Esomeprazole Sodium Lowers Acid
2026-11-16
Esomeprazole Sodium is documented as an H+/K+ ATPase inhibitor whose molecular action provides a plausible explanation for reduced gastric acid secretion. The evidence supports a mechanistic interpretation, while clinical outcomes, comparative performance, and product-specific efficacy require separate study.
How Cathepsin-Cleavable ADC Linkers Release Payloads
2026-11-15
What does a cathepsin-cleavable ADC peptide linker establish about targeted payload release? The key distinction is between chemical cleavage, intracellular liberation of a payload, and the later biological response of a cancer cell.
How Apogossypolone Links Binding to Cell Death
2026-11-14
Apogossypolone is documented as a multi-target inhibitor of antiapoptotic Bcl-2-family proteins. Its reported binding values, cell-based potency measurements, and apoptosis-related findings support a mechanistic interpretation, while differences among assays and cancer models limit direct comparison.
How Sorbitol Changes Osmotic Readouts
2026-11-13
Sorbitol can alter biochemical and cellular measurements through physicochemical effects on water activity, osmotic balance, hydration, and ice-related stress. Interpreting those changes requires separating direct effects on the assay environment from model-specific biological responses.
How Fenretinide Links FAK Signaling to Cancer Readouts
2026-11-13
Fenretinide, also called 4HPR, is described as a synthetic retinoid whose reported cancer-related effects include changes in cell growth, apoptosis-associated measurements, and migration signaling. Interpreting these observations requires separating a proposed FAK-centered mechanism from assay-specific responses and from metabolic findings in animal models.
What 5-EdU Shows in Spinal Cord Repair
2026-11-12
5-Ethynyl-2'-deoxyuridine (5-EdU) is a sensitive marker of newly synthesized DNA, but an EdU-positive signal is not equivalent to completed cell division or tissue repair. In a mouse spinal cord injury study, EdU-associated proliferation measurements contributed to a broader genetic, histological, transcriptional and functional analysis of astrocyte–microglia communication through CSF1 and IFN-β.
How Sephin1 May Prolong Stress Signaling
2026-11-12
Sephin1 is documented as disrupting the stress-responsive PPP1R15A–PP1c complex, prolonging eIF2α phosphorylation, and improving disease-associated readouts in two mouse proteostasis models. These findings support a target-linked mechanism, but their model-specific nature limits conclusions about broader efficacy.
What (R)-MG132 Can—and Cannot—Show
2026-11-11
Published evidence supports a lactate–HNRNPU K181 lactylation–PHGDH axis in cervical cancer, but the pharmacological findings center on pazopanib rather than (R)-MG132. The latter has a narrower interpretive role as a low-activity MG-132 enantiomer for proteasome-dependence controls, not as evidence that establishes the lactylation mechanism.
How to Interpret Paroxetine HCl Readouts
2026-11-11
Paroxetine Hydrochloride connects serotonin-transporter inhibition with distinct GRK2, ERK, cellular, and animal serotonin measurements. These readouts support different mechanistic claims and should not be treated as interchangeable evidence of clinical efficacy.
How PPi Hydrolysis Changes Nucleic-Acid Readouts
2026-11-10
Inorganic pyrophosphatase can influence RNA and DNA synthesis indirectly by converting inhibitory pyrophosphate into orthophosphate. The mechanism makes changes in accumulated nucleic-acid yield plausible, but yield alone does not establish improved fidelity, product length, sequence quality, or biological function.
IRP2, TFEB, and Macrophage Lysosomal Defense
2026-11-10
A mouse study links myeloid IRP2 to macrophage lysosomal competence, intracellular bacterial clearance, and protection from liver abscesses after intestinal injury. Its mechanistic data place TFEB localization downstream of HIF2-related and lactic-acid-associated signaling, while human biopsy observations provide cross-context concordance rather than a clinical treatment test.
How to Interpret ω-Muricholic Acid Biology
2026-11-09
ω-Muricholic acid is described as a rodent-associated secondary bile acid whose biological meaning depends on its place in the intestinal bile-acid pool. This article explains how microbial transformation can connect bile-acid composition with lipid metabolism, energy homeostasis and intestinal immunity, while distinguishing documented context from product-specific experimental validation.
How WEHI-539 Reveals BCL-XL Dependence
2026-11-09
Binding affinity, cellular response, and genetic context provide different levels of evidence for how WEHI-539 engages the BCL-XL apoptosis pathway. Together, the reported findings support a BAK-dependent mitochondrial mechanism while also showing why biochemical potency cannot be treated as a direct prediction of cellular response.